Revenue grew 10% year-over-year to $35M in H1 2026, with underlying growth at 18%. A proposed CMS LCD for topical oxygen therapy is set to expand Medicare coverage, supporting future growth and market leadership. VA and Medicaid remain key revenue drivers.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.